Cervical Cancer Radiotherapy Response in Dr. Hasan Sadikin General Center Hospital

Jaeni Pringgowibowo,(1*) Dodi Suardi,(2) Ruswana Anwar,(3)

(1) Departemen Obstetri & Ginekologi Fakultas Kedokteran Univesitas Padjajaran RSUP Dr. Hasan Sadikin Bandung
(2) KSM/Departemen Obstetri & Ginekologi Fakultas Kedokteran Univesitas Padjajaran RSUP Dr. Hasan Sadikin Bandung
(3) KSM/Departemen Obstetri & Ginekologi Fakultas Kedokteran Univesitas Padjajaran RSUP Dr. Hasan Sadikin Bandung
(*) Corresponding Author

Abstract


Objective: To determine the response to radiation therapy based on the characteristics of cervical cancer patients who were given radiotherapy at Hasan Sadikin Hospital in 2020.
Methods: The study was conducted using an observational analytic study method with a cross-sectional design, involving 75 cases of cervical carcinoma who were given complete radiation therapy but were not given neoadjuvant chemotherapy or surgery, which were recorded in the medical record at the Central General Hospital (RSUP) Dr. Hasan Sadikin.
Results: Response to therapy had a significant relationship (p< 0.05) with age (p 0.030), histopathological type (p 0.009), and tumor mass size (p 0.042), but had no significant relationship to cervical cancer stage (p 0.055). Further analysis found that the response to radiation therapy at stage III was highly dependent on the size of the tumor mass (p<0.001). Based on the odds ratio calculation, the response to therapy was better in patients aged 35 years 3.44 times compared to patients aged 18-34 years, cervical cancer with squamous type histopathology 5.23 times compared to adenocarcinoma type histopathology, and cervical cancer with tumor mass size. <4 cm 2.86 times compared to tumor mass size 4 cm.
Conclusion: The therapeutic response was better in cervical cancer patients who underwent complete radiation therapy in patients aged 35 years, stage III cervical cancer with tumor mass size <4 cm, squamous type histopathology, and tumor mass size <4cm.

Respon Radioterapi pada Kanker Serviks di Rumah Sakit Umum Pusat Dr. Hasan Sadikin Bandung

Abstrak
Tujuan: Untuk mengetahui respon terapi radiasi berdasarkan karakteristik pasien kanker serviks yang diberikan radioterapi di Rumah Sakit Hasan Sadikin tahun 2020.
Metode: Penelitian dilakukan menggunakan metode studi analitik observasional dengan desain potong lintang, melibatkan 75 kasus karsinoma serviks yang diberikan terapi radiasi komplit tetapi tidak diberikan kemoterapi neoadjuvant maupun tindakan operasi, yang tercatat pada rekam medis di Rumah Sakit Umum Pusat Dr. Hasan Sadikin.
Hasil: Respon terapi memiliki hubungan yang signifikan (p<0,05) terhadap usia (p 0,030), tipe histopatologi (p 0,009), dan ukuran massa (p 0,042), tetapi memiliki hubungan yang tidak bermakna terhadap stadium kanker serviks (p 0,055). Analisis lebih lanjut didapatkan bahwa respon terapi radiasi pada stadium III sangat bergantung kepada ukuran massa tumor (p<0,001). Berdasarkan penghitungan odd ratio respon terapi lebih baik didapatkan pada pasien berusia ≥35 tahun 3,44 kali dibandingkan pada usia 18-34 tahun, kanker serviks dengan histopatologi tipe skuamosa 5,23 kali dibandingkan histopatologi tipe adenokarsinoma, dan kanker serviks dengan ukuran massa tumor <4 cm 2,86 kali dibandingkan ukuran massa tumor ≥4 cm.
Kesimpulan: Respon terapi lebih baik pada pasien kanker serviks yang dilakukan terapi radiasi komplit pada pasien berusia ≥ 35 tahun, kanker serviks stadium III dengan ukuran massa tumor <4 cm, histopatologi tipe skuamosa, dan ukuran massa tumor <4cm.

Kata kunci : respon terapi, radiasi, kanker serviks


Keywords


response to therapy, radiation, cervical cancer

Full Text:

PDF

References


Wells M, Ostor A. G, Crum C.P EA. Tumors Of The Cervix. 2018. p. 266–88.

Andrijono. Kanker Serviks. Jakarta, Indonesia: Divisi Onkologi Departemen Obstetri Dan Ginekologi FKUI; 2015. 266–288 p.

Cunningham. Williams Obstetrics. 25th ed. New York: Mc Graw Hill; 2018.

Wiebe E, Denny L TG. Cancer Of The Cervix Uteri. Int J Gynecol Obstet. 2017;100–9.

World Health Organization. Latest World Cancer Statistic. Int Agency Res Cancer. 2018;

Domingo Ej, Noviani R, Rushdan M EA. Epidemiology And Prevention Of Cervical Cancer In Indonesia, Malaysia, The Philippines, Thailand And Vietnam. Vaccine. 2018;26:71–9.

Norwitz, E & Schorge J. Obstetrics And Gynecology. New York: John Willey and Sons; 2010.

Sadler TW. Langman’s Medical Embryology. 13th ed. Philadelphia: Wolters Kluwer; 2015.

Moscicki A, Hills N SS. Risk for Incident Human Papillomavirus Infection and Low Grade Squamous Intraepithelial Lesion Development in Young Females. J Am Med AsscJ Am Med Assc. 2011;285:23.

Winer RL K LA. Sexually transmitted diseases : Genital human papillomavirus infection. 4th ed. Holmes KK, Sparling PF, Stamm WE P, P, Wasserheit JN, Corey L D, editors. New York: McGraw-Hill Companies; 2009. 489–508 p.

Bruni L, Barrionuevo- Rosas L, Albero G EA. Information Centre On Hpv And Cancer (Hpv Information Centre). Human Papillomavirus And Related Diseases In The World. 2017.

Daniyal M, Akhtar N, Ahmad S EA. Update Knowledge On Cervical Cancer Incidence And Prevalence In Asia. Asian Pac J Cancer Prev. 2015;16:3617–20.

American Cancer Society. Global Cancer Facts & Figures. 3rd ed. American Cancer Society. American Cancer Society; 2017.

Kim C. Y, Tsai M. H, Osmanian C E Al. Selection Of Human Cervical Epithelial Cells That Possess Reduced Apoptotic Potential To Low-Oxygen Conditions. Cancer Res. 2017;4200–4.

Sankaranarayan R WR. A Practical Manual On Visual Screening For Cervical Neoplasia. 2018;

Hung Vh, Bourgain C, Vlastos G E Al. Prognostic Value Of Histopathology And Trends In Cervical Cancer: A Seer Population Study. BMC Cancer. 2018;1–13.

Oncology PSFCOG. Revised Figo Staging For Carcinoma Of The Vulva, Cervix, And Endometrium. Int J Gynaecol Obs. 2018;108(2):176.

Bose Mv RT. Assessment Of The Radiation Sensitivity Of Cervical Cancer Cell Line. Method Mol Biol. 2017;1249:351–62.

Peters Wa Iii, Liu Py, Barrett Rj Jr E Al. Concurrent Chemotherapy And Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone As Adjuvant Therapy After Radical Surgery In High- Risk Early- Stage Cancer Of The Cervix. J Clin Oncol. 2020;18:1606–13.

A.W Flyes, Milosevic M, Wong R E Al. Oxygenation Predicts Radiation Response And Survival In Patients With Cervix Cancer. Radiother Oncol. 2018;149–56.

Mundt A.J, Lujan A.E, Rotmensch J E Al. Intensity- Modulated Whole Pelvic Radiotherapy In Women With Gynecologic Malignancies. Int J ,Radiation Oncol Biol Phys. 2017;52:1330–7.

Therasse P, Arbuck Sg, Eisenhauer Ea E Al. New Guidelines To Evaluate The Response To Treatment In Solid Tumor. J NatlCancer Inst. 2019;92:205–16.

Friedlander M GM. Guidelines For The Treatment Of Recurrent And Metastatic Cervical Cancer. Off J Soc Transl Oncol. 2017;

Oj P. Measuring Response In Solid Tumors: Comparison Of Recist And Who Response Criteria. Jpn J Clin Oncol. 2018;33(10):533–7.

Bahar I, Tjokroprawiro Ba SE Al. Radiotherapy Respon Of Advance Cervical Cancer Types Of Cervical Cancer At Dr. Soetomo Hospital Surabaya. Maj Obstet Dan Ginekol. 2018;31:48–55.

Achmadi. Karakteristik Penderita Kanker Serviks 2006 – 2010 Di RSUD Dr. Soetomo. Maj Obstet Dan Ginekol. 2011;19:128–33.




DOI: http://dx.doi.org/10.24198/obgynia/v5n1.340

Refbacks

  • There are currently no refbacks.





     
       

Creative Commons License
Indonesian Journal of Obstetrics & Gynecology Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
  Web Analytics
  View My Stat